Aberdeen Wealth Management’s Labcorp LH Stock Holding History

Aberdeen Wealth Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,601	Closed	-$326K	–	171
2024 Q2	$326K	Buy	+1,601	New	+$326K	0.22%	114

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aberdeen Wealth Management's LH Position: Q3 2024 in Review

Aberdeen Wealth Management sold out of Labcorp (LH) in Q3 2024, closing a stake of 1,601 shares — an estimated $326K sold.

Aberdeen Wealth Management first reported a position in LH in Q2 2024 and held it in 1 quarter. The position peaked at $326K in Q2 2024. 918 funds tracked by Wall St. Rank hold LH as of Q3 2024.

Aberdeen Wealth Management reported no remaining Labcorp position as of Q3 2024 after selling out during the quarter.
Aberdeen Wealth Management sold 1,601 Labcorp shares in Q3 2024, an estimated $326K.
Aberdeen Wealth Management first reported a position in Labcorp in Q2 2024 and held it in 1 quarter.
Aberdeen Wealth Management's Labcorp position peaked at $326K in Q2 2024.
918 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.

Based on Aberdeen Wealth Management's 13F filing for Q3 2024, filed 8 Nov 2024.